Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia

Abstract Background Patients with X-linked agammaglobulinemia (XLA) are protected against invasive bacterial infections due to IgG replacement therapy, but are still at higher risk for mucosal infections of the gut and respiratory tract. This might be explained by to the lack of IgA and IgM, as thes...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jeroen D. Langereis, Joannes F. M. Jacobs, Marien I. de Jonge, Marcel van Deuren
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2019-05-01
Saila:	Journal of Translational Medicine
Gaiak:	Agammaglobulinemia Haemophilus influenzae IgA IgM Agglutination Complement
Sarrera elektronikoa:	http://link.springer.com/article/10.1186/s12967-019-1928-x
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!